Boundless Bio Stock Forecast - Polynomial Regression
| BOLD Stock | USD 1.21 0.01 0.82% |
Boundless Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Boundless Bio stock prices and determine the direction of Boundless Bio Common's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Boundless Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Boundless Bio's share price is approaching 44 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Boundless Bio, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.58) | EPS Estimate Current Year (2.47) | EPS Estimate Next Year (2.10) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.58) |
Using Boundless Bio hype-based prediction, you can estimate the value of Boundless Bio Common from the perspective of Boundless Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of Boundless Bio Common on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.54. Boundless Bio after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Boundless | Build AI portfolio with Boundless Stock |
Boundless Bio Additional Predictive Modules
Most predictive techniques to examine Boundless price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Boundless using various technical indicators. When you analyze Boundless charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Boundless Bio Polynomial Regression Price Forecast For the 30th of January
Given 90 days horizon, the Polynomial Regression forecasted value of Boundless Bio Common on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.54.Please note that although there have been many attempts to predict Boundless Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Boundless Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Boundless Bio Stock Forecast Pattern
| Backtest Boundless Bio | Boundless Bio Price Prediction | Buy or Sell Advice |
Boundless Bio Forecasted Value
In the context of forecasting Boundless Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Boundless Bio's downside and upside margins for the forecasting period are 0.01 and 4.10, respectively. We have considered Boundless Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Boundless Bio stock data series using in forecasting. Note that when a statistical model is used to represent Boundless Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.2065 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0253 |
| MAPE | Mean absolute percentage error | 0.0209 |
| SAE | Sum of the absolute errors | 1.5406 |
Predictive Modules for Boundless Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Boundless Bio Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Boundless Bio After-Hype Price Density Analysis
As far as predicting the price of Boundless Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Boundless Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Boundless Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Boundless Bio Estimiated After-Hype Price Volatility
In the context of predicting Boundless Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Boundless Bio's historical news coverage. Boundless Bio's after-hype downside and upside margins for the prediction period are 0.06 and 4.12, respectively. We have considered Boundless Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Boundless Bio is very risky at this time. Analysis and calculation of next after-hype price of Boundless Bio Common is based on 3 months time horizon.
Boundless Bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Boundless Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boundless Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Boundless Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 2.91 | 0.00 | 0.01 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.21 | 1.21 | 0.00 |
|
Boundless Bio Hype Timeline
Boundless Bio Common is currently traded for 1.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Boundless is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.2%. %. The volatility of related hype on Boundless Bio is about 9387.1%, with the expected price after the next announcement by competition of 1.20. About 58.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. Boundless Bio Common recorded a loss per share of 2.66. The entity had not issued any dividends in recent years. The firm had 1:25 split on the March 31, 2011. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Historical Fundamental Analysis of Boundless Bio to cross-verify your projections.Boundless Bio Related Hype Analysis
Having access to credible news sources related to Boundless Bio's direct competition is more important than ever and may enhance your ability to predict Boundless Bio's future price movements. Getting to know how Boundless Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Boundless Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QTTB | Q32 Bio | (0.43) | 8 per month | 4.90 | 0.08 | 7.51 | (8.57) | 85.16 | |
| NXTC | NextCure | 0.04 | 9 per month | 5.20 | 0.06 | 11.65 | (8.43) | 43.11 | |
| PSTV | Plus Therapeutics | 0.01 | 10 per month | 0.00 | (0.17) | 8.93 | (8.82) | 48.30 | |
| INTS | Intensity Therapeutics Common | 0.02 | 5 per month | 8.39 | 0.09 | 12.20 | (14.04) | 433.59 | |
| ITRM | Iterum Therapeutics PLC | 0.02 | 9 per month | 0.00 | (0.17) | 9.38 | (8.82) | 28.58 | |
| ANTX | AN2 Therapeutics | 0.07 | 10 per month | 3.29 | 0.01 | 5.56 | (4.58) | 32.31 | |
| PLUR | Pluri Inc | (0.39) | 8 per month | 0.00 | (0.03) | 9.30 | (6.23) | 31.25 | |
| RLYB | Rallybio Corp | (0.06) | 6 per month | 3.01 | 0.05 | 8.33 | (5.71) | 21.25 | |
| SONN | Sonnet Biotherapeutics Holdings | (0.43) | 15 per month | 0.00 | (0.02) | 19.48 | (18.21) | 69.59 | |
| TAOX | TAO Synergies | 0.84 | 2 per month | 0.00 | (0.07) | 12.66 | (10.43) | 36.28 |
Other Forecasting Options for Boundless Bio
For every potential investor in Boundless, whether a beginner or expert, Boundless Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Boundless Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Boundless. Basic forecasting techniques help filter out the noise by identifying Boundless Bio's price trends.Boundless Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boundless Bio stock to make a market-neutral strategy. Peer analysis of Boundless Bio could also be used in its relative valuation, which is a method of valuing Boundless Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Boundless Bio Market Strength Events
Market strength indicators help investors to evaluate how Boundless Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Boundless Bio shares will generate the highest return on investment. By undertsting and applying Boundless Bio stock market strength indicators, traders can identify Boundless Bio Common entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.21 | |||
| Day Typical Price | 1.21 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 44.64 |
Boundless Bio Risk Indicators
The analysis of Boundless Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Boundless Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting boundless stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.1 | |||
| Standard Deviation | 2.9 | |||
| Variance | 8.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Boundless Bio
The number of cover stories for Boundless Bio depends on current market conditions and Boundless Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Boundless Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Boundless Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Boundless Bio Short Properties
Boundless Bio's future price predictability will typically decrease when Boundless Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Boundless Bio Common often depends not only on the future outlook of the potential Boundless Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Boundless Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17 M | |
| Cash And Short Term Investments | 152.1 M |
Check out Historical Fundamental Analysis of Boundless Bio to cross-verify your projections. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Biotechnology sector continue expanding? Could Boundless diversify its offerings? Factors like these will boost the valuation of Boundless Bio. Projected growth potential of Boundless fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Boundless Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Boundless Bio Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio's value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Boundless Bio's market value can be influenced by many factors that don't directly affect Boundless Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Boundless Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Boundless Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Boundless Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.